OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Communications is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Issue Information	673
Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study	619
Issue Information	445
	392
Fascin lysine 471 acetylation cooperates with serine 39 phosphorylation to inhibit actin‐bundling activity and tumor metastasis in esophageal squamous cell carcinoma	346
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation	234
Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study	211
Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma	203
Current status and perspectives of esophageal cancer: a comprehensive review	194
Single‐cell transcriptomics and epigenomics point to CD58‐CD2 interaction in controlling primary melanoma growth and immunity	187
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update	171
Kindlin‐1 drives early steps of breast cancer metastasis	167
	150
Nine‐fold variation of risk of advanced colorectal neoplasms according to smoking and polygenic risk score: Results from a cross‐sectional study in a large screening colonoscopy cohort	145
	130
Issue Information	127
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives	125
Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy	119
Issue Information	118
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer	117
Research trends of cancer metabolism: analysis from a Chinese perspective	114
Single‐cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions	111
Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward	101
	95
Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial	93

Impact of pre‐existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study	89
Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity	84
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates	83
Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with h	82
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinica	78
Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrence	78
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer	77
A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer	77
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases	76
Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2^−/− acute myeloid leukemia	69
P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer	69
Multifunctional inorganic nanomaterials for cancer photoimmunotherapy	66
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program	65
The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential	64
Issue Information	63
	63
Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2‐mediated increase of SOAT2 RNA methylation	62
A strong internal promoter drives massive expression of YEATS‐domain devoid MLLT3 transcripts in HSC and most lethal AML	61
Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma	60
Incidence of and survival with bone and soft tissue sarcoma: A nation‐wide study over four decades	60
	54
Cover Image, Volume 42, Issue 1	54
Impact of small molecule‐mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism	52
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2	52
Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: A pooled analysis of individual patient data from three randomized trials	51
Association between antipsychotic agents and risk of lung cancer: a nested case‐control study	51